<VariationArchive VariationID="189229" VariationName="NM_001363711.2(DUOX2):c.2895_2898del (p.Phe966fs)" VariationType="Deletion" Accession="VCV000189229" Version="29" RecordType="classified" NumberOfSubmissions="14" NumberOfSubmitters="14" DateLastUpdated="2024-06-23" DateCreated="2017-03-08" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="187125" VariationID="189229">
      <GeneList>
        <Gene Symbol="DUOX2" FullName="dual oxidase 2" GeneID="50506" HGNC_ID="HGNC:13273" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="45092650" stop="45114172" display_start="45092650" display_stop="45114172" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="45384851" stop="45406358" display_start="45384851" display_stop="45406358" Strand="-" />
          </Location>
          <OMIM>606759</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001363711.2(DUOX2):c.2895_2898del (p.Phe966fs)</Name>
      <CanonicalSPDI>NC_000015.10:45101227:GAACGA:GA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="45101228" stop="45101231" display_start="45101228" display_stop="45101231" variantLength="4" positionVCF="45101227" referenceAlleleVCF="TGAAC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="45393426" stop="45393429" display_start="45393426" display_stop="45393429" variantLength="4" positionVCF="45393425" referenceAlleleVCF="TGAAC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>F966fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.45101230_45101233del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.45101230_45101233del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.45393428_45393431del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.45393428_45393431del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009447.1" sequenceAccession="NG_009447" sequenceVersion="1" change="g.17931_17934del">
            <Expression>NG_009447.1:g.17931_17934del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363711.2" sequenceAccession="NM_001363711" sequenceVersion="2" change="c.2895_2898del" MANESelect="true">
            <Expression>NM_001363711.2:c.2895_2898del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350640.1" sequenceAccession="NP_001350640" sequenceVersion="1" change="p.Phe966fs">
            <Expression>NP_001350640.1:p.Phe966fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014080.5" sequenceAccession="NM_014080" sequenceVersion="5" change="c.2895_2898del">
            <Expression>NM_014080.5:c.2895_2898del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_054799.4" sequenceAccession="NP_054799" sequenceVersion="4" change="p.Phe966fs">
            <Expression>NP_054799.4:p.Phe966fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014080.4" sequenceAccession="NM_014080" sequenceVersion="4" change="c.2895_2898delGTTC">
            <Expression>NM_014080.4:c.2895_2898delGTTC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014080.5" sequenceAccession="NM_014080" sequenceVersion="5" change="c.2895_2898delGTTC">
            <Expression>NM_014080.5:c.2895_2898delGTTC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA199161" DB="ClinGen" />
        <XRef Type="rs" ID="530719719" DB="dbSNP" />
      </XRefList>
      <GlobalMinorAlleleFrequency Value="0.00180" Source="1000 Genomes Project" MinorAllele="GA" />
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001363711.2(DUOX2):c.2895_2898del (p.Phe966fs) AND Familial thyroid dyshormonogenesis" Accession="RCV000169659" Version="8">
        <ClassifiedConditionList TraitSetID="48418">
          <ClassifiedCondition DB="MedGen" ID="C4273748">Familial thyroid dyshormonogenesis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-06-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001363711.2(DUOX2):c.2895_2898del (p.Phe966fs) AND not provided" Accession="RCV000256134" Version="14">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-31" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001363711.2(DUOX2):c.2895_2898del (p.Phe966fs) AND Inborn genetic diseases" Accession="RCV000624099" Version="5">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-03-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001363711.2(DUOX2):c.2895_2898del (p.Phe966fs) AND Nongoitrous Euthyroid Hyperthyrotropinemia" Accession="RCV000755102" Version="1">
        <ClassifiedConditionList TraitSetID="46390">
          <ClassifiedCondition>Nongoitrous Euthyroid Hyperthyrotropinemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2017-01-01" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001363711.2(DUOX2):c.2895_2898del (p.Phe966fs) AND Congenital hypothyroidism" Accession="RCV000991174" Version="1">
        <ClassifiedConditionList TraitSetID="9695">
          <ClassifiedCondition DB="MedGen" ID="C0010308">Congenital hypothyroidism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-01-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001363711.2(DUOX2):c.2895_2898del (p.Phe966fs) AND Thyroid dyshormonogenesis 6" Accession="RCV001265562" Version="9">
        <ClassifiedConditionList TraitSetID="1108">
          <ClassifiedCondition DB="MedGen" ID="C1846632">Thyroid dyshormonogenesis 6</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-21" SubmissionCount="6">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001363711.2(DUOX2):c.2895_2898del (p.Phe966fs) AND DUOX2-related disorder" Accession="RCV003398870" Version="5">
        <ClassifiedConditionList TraitSetID="90048">
          <ClassifiedCondition>DUOX2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-31" NumberOfSubmissions="14" NumberOfSubmitters="14" DateCreated="2017-03-08" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12110737</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16322276</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18765513</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20972728</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21565790</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24423310</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24735383</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26990548</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27525530</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27821020</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28666341</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30084132</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30240412</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30487145</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31044655</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32765423</ID>
        </Citation>
        <DescriptionHistory Dated="2018-04-14">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="46390" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="41375" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nongoitrous Euthyroid Hyperthyrotropinemia</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9695" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="9473" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital hypothyroidism</ElementValue>
                <XRef ID="Congenital+Hypothyroidism/1842" DB="Genetic Alliance" />
                <XRef ID="HP:0000851" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0018612" DB="MONDO" />
                <XRef ID="190268003" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1487" />
                <XRef ID="1487" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG ACT Sheets, 2010">
                <ID Source="PubMed">21938795</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2009">
                <URL>https://www.acmg.net/PDFLibrary/TSH-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics Algorithm, Congenital Hypothyroidism (TSH), 2009</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2009">
                <URL>https://www.acmg.net/PDFLibrary/T4-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Congenital Hypothyroidism (T4), 2009</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Congenital-Hypothyroidism-Transition.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Transition to Adult Health Care ACT Sheet, Congenital Hypothyroidism, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng145</URL>
                <CitationText>UK NICE Guideline NG145, Thyroid disease: assessment and management, 2023</CitationText>
              </Citation>
              <XRef ID="442" DB="Orphanet" />
              <XRef ID="C0010308" DB="MedGen" />
              <XRef ID="MONDO:0018612" DB="MONDO" />
              <XRef Type="primary" ID="HP:0000851" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1108" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4558" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">THYROID HORMONOGENESIS, GENETIC DEFECT IN, 6</ElementValue>
                <XRef Type="MIM" ID="607200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Thyroid dyshormonogenesis 6</ElementValue>
                <XRef ID="MONDO:0011792" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 6</ElementValue>
                <XRef Type="MIM" ID="607200" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TDH6</ElementValue>
                <XRef Type="MIM" ID="607200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">TH6</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18193" />
                <XRef ID="18193" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="95716" DB="Orphanet" />
              <XRef ID="C1846632" DB="MedGen" />
              <XRef ID="MONDO:0011792" DB="MONDO" />
              <XRef Type="MIM" ID="607200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="90048" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="70291" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">DUOX2-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">DUOX2-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="48418" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="42474" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial thyroid dyshormonogenesis</ElementValue>
                <XRef ID="MONDO:0010132" DB="MONDO" />
                <XRef ID="42989413" DB="NCBI for submitter" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16843" />
                <XRef ID="16843" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="95716" DB="Orphanet" />
              <XRef ID="C4273748" DB="MedGen" />
              <XRef ID="MONDO:0010132" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2253885" SubmissionDate="2020-01-06" DateLastUpdated="2020-01-12" DateCreated="2020-01-12">
        <ClinVarSubmissionID localKey="NM_014080.4:c.2895_2898delGTTC|Congenital hypothyroidism" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001142447" DateUpdated="2020-01-12" DateCreated="2020-01-12" Type="SCV" Version="1" SubmitterName="Reproductive Health Research and Development, BGI Genomics" OrgID="507058" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-01-06">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>NM_014080.4:c.2895_2898delGTTC in the DUOX2 gene has an allele frequency of 0.012 in European (Finnish) subpopulation in the gnomAD database.This variant is located in the 22nd exon (a total of 34 exons in the NM_014080.4 transcript), therefore, it is predicted to result in nonsense-mediated mRNA decay. Muzza et al reported four independent Italian families with dyshormonogenic Congenital Hypothyroidism, revealing compound heterozygous in trans (PMID: 24423310). Functional studies confirmed that this mutation is responsible for the defect in H2O2 production (PMID: 21565790). Taken together, we interprete this variant as Pathogenic/Likely pathogenic. ACMG/AMP criteria applied: PVS1; PS3; PM3_Strong</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DUOX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014080.4:c.2895_2898delGTTC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Congenital hypothyroidism</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6087587</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7575435" SubmissionDate="2023-10-19" DateLastUpdated="2023-10-28" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="20200124054_1" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004047016" DateUpdated="2023-10-28" DateCreated="2023-10-28" Type="SCV" Version="1" SubmitterName="Neuberg Centre For Genomic Medicine, NCGM" OrgID="508108" OrganizationCategory="laboratory" OrgAbbreviation="NCGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The frameshift c.2895_2898del (p.Phe966SerfsTer29) variant has been reported previously in homozygous and compound heterozygous state in patients affected with dyshormonogenic congenital hypothyroidism. Experimental studies have shown that this frameshift variant results in nonsense mediated decay (Muzza M. et al. 2014). The variant is reported with the allele frequency of 0.3% in gnomAD Exomes and 0.2% in 1000 Genomes. It has been submitted to ClinVar with varying interpretations: Pathogenic/ Likely Pathogenic. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0031508" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0008263" />
              </Trait>
              <Comment>Clinical symptoms : Bad obstetric history Family history: couple had 2 girl children both died at the age of 1.5 years, 1st child succumbed due to status epilepticum and 2nd child due to lower respiratory tract infection. Both had global developmental delay, hearing and vision loss, progressive macrocephaly, abdominal distension, recurrent lower respiratory tract infections and seizures from 7th month of life. Investigation- CT Brain was done revealed B/L basal ganglia and parietal lobe calcification, presence of B/L grey fundal glow suspected as CMV infection or macular hypoplasia.</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DUOX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001363711.2:c.2895_2898del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13901154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1446648" SubmissionDate="2024-04-19" DateLastUpdated="2024-05-01" DateCreated="2018-04-15">
        <ClinVarSubmissionID localKey="a802214|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000742851" DateUpdated="2024-05-01" DateCreated="2018-04-15" Type="SCV" Version="5" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12110737</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21565790</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24423310</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26990548</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27525530</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27821020</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28666341</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30084132</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30240412</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30487145</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31044655</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32765423</ID>
          </Citation>
          <Comment>The c.2895_2898delGTTC (p.F966Sfs*29) alteration, located in exon 22 (coding exon 21) of the DUOX2 gene, results from a deletion of 4 nucleotides from position 2895 to 2898, causing a translational frameshift with a predicted alternate stop codon after 29 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from the Genome Aggregation Database (gnomAD), the DUOX2 c.2895_2898delGTTC alteration was observed in 0.29% (829/282026) of total alleles studied, with a frequency of 1.16% (292/25102) in the European (Finnish) subpopulation. This mutation has been observed in the homozygous, heterozygous, and compound heterozygous states in multiple unrelated individuals with both transient and permanent congenital hypothyroidism (CH) (Moreno, 2002; De Marco, 2011; Muzza, 2014; Abul&amp;iacute;, 2016; Srichomkwun, 2017; Kizys, 2017; Repnikova, 2018; Makretskaya, 2018; Peters, 2019). This amino acid position is highly conserved in available vertebrate species. Functional in vitro analyses performed on this mutation demonstrate nearly complete inhibition of hydrogen peroxide generation (De Marco, 2011; Muzza, 2014) and reduced cell surface protein expression compared to wildtype (De Marco, 2011). Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DUOX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014080.4:c.2895_2898delGTTC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>AVA4 Submission_Through01042023</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_1</SubmissionName>
          <SubmissionName>NovelandUpdateExomeDeposit_ExomeProgenyThrough080120</SubmissionName>
          <SubmissionName>exome clinvar deposit 2.18.18</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9799107" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2024-06-09">
        <ClinVarSubmissionID localKey="NM_014080.5:c.2895_2898del|OMIM:607200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005049380" DateUpdated="2024-06-09" DateCreated="2024-06-09" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014080.5:c.2895_2898del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>WES_20231129_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="977009" SubmissionDate="2017-02-17" DateLastUpdated="2017-03-08" DateCreated="2017-03-08">
        <ClinVarSubmissionID localKey="12898857" />
        <ClinVarAccession Accession="SCV000511719" DateUpdated="2017-03-08" DateCreated="2017-03-08" Type="SCV" Version="1" SubmitterName="Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics" OrgID="505698" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-02-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>Homo sapiens</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>Illumina</NamePlatform>
              <TypePlatform>Sequencing</TypePlatform>
              <ResultType>variant call</ResultType>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0.00197</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="15" Strand="+" alternateAllele="-" referenceAllele="GAAC" start="45393426" stop="45393429" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1728707" SubmissionDate="2018-05-22" DateLastUpdated="2019-02-17" DateCreated="2019-02-17">
        <ClinVarSubmissionID localKey="NM_014080.4:c.2895_2898delGTTC|Nongoitrous Euthyroid Hyperthyrotropinemia" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000882920" DateUpdated="2019-02-17" DateCreated="2019-02-17" Type="SCV" Version="1" SubmitterName="University of Washington Center for Mendelian Genomics, University of Washington" OrgID="505516" OrganizationCategory="laboratory" OrgAbbreviation="UW-CMG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
            <Citation>
              <ID Source="PubMed">27821020</ID>
            </Citation>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DUOX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014080.4:c.2895_2898delGTTC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Nongoitrous Euthyroid Hyperthyrotropinemia</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4062622</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2851392" SubmissionDate="2020-07-31" DateLastUpdated="2020-11-21" DateCreated="2020-11-21">
        <ClinVarSubmissionID localKey="c.2895_2898del" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001443718" DateUpdated="2020-11-21" DateCreated="2020-11-21" Type="SCV" Version="1" SubmitterName="Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego" OrgID="506081" OrganizationCategory="laboratory" OrgAbbreviation="RCIGM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-09-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>A heterozygous c.2895_2898del (p.Phe966SerfsTer29) variant in DUOX2, also referred to as S965fsX994 in the literature, was detected in this individual. This four bp deletion in exon 22 of DUOX2, sometimes referred to as S965fsX994 in the literature, causes a frameshift and a premature stop codon at residue 994, and is predicted to result in loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. In the gnomAD population database this variant is present as heterozygous at a frequency of 0.297% (820/276458) and as homozygous in six individuals. This variant is a recurrent pathogenic alteration that has been reported in the literature as homozygous or compound heterozygous in multiple individuals with partial iodide-organification defects and transient or permanent congenital hypothyroidism (PMID: 12110737, 21565790, 24423310, 28666341, 31044655). This variant was shown to results in nonsense mediated mRNA decay (PMID: 24423310) and complete inhibition of the hydrogen peroxide-generating activity as well as decreased cell surface expression in in-vitro experiments based on expression of wild-type and mutant cDNA constructs in Hela cells (PMID: 24423310, 21565790). ClinVar contains an entry for this variant (Variation ID: 189229). Based on the available evidence, the c.2895_2898del (p.Phe966SerfsTer29) variant is classified as Likely Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DUOX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014080.4:c.2895_2898del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">THYROID DYSHORMONOGENESIS 6</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7860438</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4932918" SubmissionDate="2022-05-21" DateLastUpdated="2022-05-28" DateCreated="2022-05-28">
        <ClinVarSubmissionID localKey="NC_000015.10:g.45101228_45101231delGAAC|OMIM:607200" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002519586" DateUpdated="2022-05-28" DateCreated="2022-05-28" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fxi2k7be/mendelics_assertion_criteria_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DUOX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.10:g.45101228_45101231delGAAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_033</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5403720" SubmissionDate="2022-12-14" DateLastUpdated="2022-12-17" DateCreated="2022-12-17">
        <ClinVarSubmissionID localKey="sa_pathology/genomics_unit/vc32058" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002761908" DateUpdated="2022-12-17" DateCreated="2022-12-17" Type="SCV" Version="1" SubmitterName="Genetics and Molecular Pathology, SA Pathology" OrgID="506043" OrganizationCategory="laboratory" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DUOX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_15428</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014080.5:c.2895_2898delGTTC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_37</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="616220" SubmissionDate="2022-08-10" DateLastUpdated="2023-03-04" DateCreated="2016-10-09">
        <ClinVarSubmissionID localKey="GDXSV:235570" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000321567" DateUpdated="2023-03-04" DateCreated="2016-10-09" Type="SCV" Version="11" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Reported in the published literature, as S965fsX994 due to alternate nomenclature, in the heterozygous or compound heterozygous state in multiple individuals with partial iodide-organification defects and transient or permanent congenital hypothyroidism (Moreno et al., 2002; De Marco et al., 2011; Muzza et al., 2014); Published functional studies demonstrate complete inhibition of the hydrogen peroxide-generating activity as well as decreased cell surface expression (De Marco et al., 2011); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 27821020, 30487145, 30609409, 31030636, 16322276, 24423310, 12110737, 28666341, 26990548, 30084132, 30240412, 31044655, 31028847, 32109542, 33124651, 31980526, 31589614, 33144682, 32765423, 34426522, 34248839, 21565790)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DUOX2" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:18642</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014080.4:c.2895_2898del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_123_20220810054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_58_20211001044204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_93_20220309054204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7135999" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="8c2b27a061395ae01bf39c4b33229526ac2b92998679fb0c283886d6ae34bb23|OMIM:607200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003831676" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014080.4:c.2895_2898del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1845290" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="2214535|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000951183" DateUpdated="2024-02-20" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12110737</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18765513</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21565790</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24423310</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24735383</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21565790</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24423310</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Phe966Serfs*29) in the DUOX2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DUOX2 are known to be pathogenic (PMID: 12110737, 18765513, 21565790, 24423310, 24735383). This variant is present in population databases (rs530719719, gnomAD 1.1%), and has an allele count higher than expected for a pathogenic variant. This premature translational stop signal has been observed in individual(s) with partial iodide organification defect (PMID: 21565790, 24423310). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 189229). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DUOX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.45393426_45393429del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7698446" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="781842|DUOX2-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004119233" DateUpdated="2024-03-16" DateCreated="2023-11-20" Type="SCV" Version="2" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The DUOX2 c.2895_2898delGTTC variant is predicted to result in a frameshift and premature protein termination (p.Phe966Serfs*29). This variant has been reported in homozygous and compound heterozygous individuals diagnosed with congenital hypothyroidism (Muzza et al. 2013. PubMed ID: 24423310; Makretskaya et al. 2018. PubMed ID: 30240412). This variant in the heterozygous state may be associated with some mild clinical features of the disease (Patient 4 in Moreno et al. 2002. PubMed ID: 12110737; F23 in Nicholas et al. 2016. PubMed ID: 27525530). In the ClinVar database, this variant has been listed as likely pathogenic or pathogenic by multiple submitters (https://preview.ncbi.nlm.nih.gov/clinvar/variation/189229/). This variant is reported in 1.2% of alleles in individuals of European (Finnish) descent in gnomAD, including 6 homozygotes. Frameshift variants in DUOX2 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DUOX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014080.4:c.2895_2898delGTTC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DUOX2-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="399797" SubmissionDate="2024-04-19" DateLastUpdated="2024-04-20" DateCreated="2015-04-01">
        <ClinVarSubmissionID localKey="42989413|Orphanet:ORPHA95716" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV000221187" DateUpdated="2024-04-20" DateCreated="2015-04-01" Type="SCV" Version="5" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21565790</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20972728</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24423310</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12110737</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16322276</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30240412</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27821020</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26990548</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28666341</ID>
          </Citation>
          <Comment>The p.Phe966SerfsX29 variant in DUOX2 has been reported in at least 30 individuals with congenital hypothyroidism, of whom 7 were homozygous, 4 were reportedly compound heterozygous (although only 2 individuals were compound heterozygous for a clearly pathogenic variant), and 19 were heterozygous (Varela 2006 PMID:16322276, Chiesa 2010 PMID:20972728, De Marco 2011 PMID:21565790, Moreno 2012 PMID:12110737, Muzza 2014 PMID:24423310, Kizys 2017 PMID:28666341, Srichomkwun 2017 PMID:27821020, Makretskaya 2018 PMID:30240412). It has also been identified in 0.29% (829/281197) of total chromosomes, including 1.16% of Finnish chromosomes and 6 homozygous individuals, by gnomAD (http://gnomad.broadinstitute.org). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. Functional studies demonstrate that this variant results in complete inhibition of hydrogen peroxide-generating activity as well as decreased cell surface expression compared to wild-type (De Marco 2011 PMID:21565790). This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 966 and leads to a premature termination codon 29 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the DUOX2 gene is an established disease mechanism in autosomal recessive congenital hypothyroidism. Finally, this variant has been reported as pathogenic and likely pathogenic in ClinVar (Variation ID 189229). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive congenital hypothyroidism. ACMG/AMP Criteria applied: PVS1, PM3, PS3_Supporting.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DUOX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_014080.5:exon 22</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.10:g.45101228_45101231delGAAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA95716" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14389831</SubmissionName>
          <SubmissionName>SUB7546315</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2253885" TraitType="Disease" MappingType="Name" MappingValue="Congenital hypothyroidism" MappingRef="Preferred">
        <MedGen CUI="C0010308" Name="Congenital hypothyroidism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9799107" TraitType="Disease" MappingType="XRef" MappingValue="607200" MappingRef="OMIM">
        <MedGen CUI="C1846632" Name="Thyroid dyshormonogenesis 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5403720" TraitType="Disease" MappingType="XRef" MappingValue="607200" MappingRef="OMIM">
        <MedGen CUI="C1846632" Name="Thyroid dyshormonogenesis 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1446648" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1845290" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7698446" TraitType="Disease" MappingType="Name" MappingValue="DUOX2-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="DUOX2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4932918" TraitType="Disease" MappingType="XRef" MappingValue="607200" MappingRef="OMIM">
        <MedGen CUI="C1846632" Name="Thyroid dyshormonogenesis 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7575435" TraitType="Finding" MappingType="XRef" MappingValue="HP:0031508" MappingRef="HP">
        <MedGen CUI="C4531077" Name="Abnormal circulating thyroid hormone concentration" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1728707" TraitType="Disease" MappingType="Name" MappingValue="Nongoitrous Euthyroid Hyperthyrotropinemia" MappingRef="Preferred">
        <MedGen CUI="None" Name="Nongoitrous Euthyroid Hyperthyrotropinemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7135999" TraitType="Disease" MappingType="XRef" MappingValue="607200" MappingRef="OMIM">
        <MedGen CUI="C1846632" Name="Thyroid dyshormonogenesis 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="399797" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA95716" MappingRef="Orphanet">
        <MedGen CUI="C4273748" Name="Familial thyroid dyshormonogenesis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2851392" TraitType="Disease" MappingType="Name" MappingValue="THYROID DYSHORMONOGENESIS 6" MappingRef="Preferred">
        <MedGen CUI="C1846632" Name="Thyroid dyshormonogenesis 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7575435" TraitType="Finding" MappingType="XRef" MappingValue="HP:0008263" MappingRef="HP">
        <MedGen CUI="C1848800" Name="Thyroid defect in oxidation and organification of iodide" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="977009" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7575435" TraitType="Disease" MappingType="XRef" MappingValue="607200" MappingRef="OMIM">
        <MedGen CUI="C1846632" Name="Thyroid dyshormonogenesis 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="616220" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

